The scientific context and basis of the pharmacologic management of dry eyes

Ophthalmol Clin North Am. 2005 Dec;18(4):475-84, v. doi: 10.1016/j.ohc.2005.07.003.

Abstract

The ability to diagnose and treat dry eye has improved dramatically over the last decade as understanding of disease mechanisms and pathology has improved. The ability to screen patients for dry eye before ophthalmic plastics procedures has improved, and the ability to manage and treat dry eye in patients after surgery also has improved.

Publication types

  • Review

MeSH terms

  • Dry Eye Syndromes / drug therapy*
  • Dry Eye Syndromes / metabolism
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use*
  • Ophthalmic Solutions
  • Tears / drug effects
  • Tears / metabolism
  • Tetracyclines / administration & dosage
  • Tetracyclines / therapeutic use*
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Ophthalmic Solutions
  • Tetracyclines